Annual Retained Earnings
$409.27 M
+$137.54 M+50.62%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual retained earnings is currently $409.27 million, with the most recent change of +$137.54 million (+50.62%) on 31 December 2023. During the last 3 years, it has risen by +$291.50 million (+247.51%). AMPH annual retained earnings is now at all-time high.AMPH Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$530.82 M
+$40.43 M+8.24%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly retained earnings is currently $530.82 million, with the most recent change of +$40.43 million (+8.24%) on 30 September 2024. Over the past year, it has increased by +$157.72 million (+42.27%). AMPH quarterly retained earnings is now at all-time high.AMPH Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.6% | +42.3% |
| 3 y3 years | +247.5% | +230.6% |
| 5 y5 years | +506.5% | +352.2% |
AMPH Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +247.5% | at high | +230.6% |
| 5 y | 5 years | at high | +506.5% | at high | +356.1% |
| alltime | all time | at high | +578.5% | at high | +905.5% |
Amphastar Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $530.82 M(+8.2%) |
| June 2024 | - | $490.39 M(+8.4%) |
| Mar 2024 | - | $452.44 M(+10.5%) |
| Dec 2023 | $409.27 M(+50.6%) | $409.27 M(+9.7%) |
| Sept 2023 | - | $373.10 M(+15.2%) |
| June 2023 | - | $323.88 M(+8.8%) |
| Mar 2023 | - | $297.75 M(+9.6%) |
| Dec 2022 | $271.72 M(+50.7%) | $271.72 M(+14.3%) |
| Sept 2022 | - | $237.81 M(+7.2%) |
| June 2022 | - | $221.94 M(+8.5%) |
| Mar 2022 | - | $204.59 M(+13.4%) |
| Dec 2021 | $180.34 M(+53.1%) | $180.34 M(+12.3%) |
| Sept 2021 | - | $160.58 M(+23.0%) |
| June 2021 | - | $130.58 M(+6.3%) |
| Mar 2021 | - | $122.81 M(+4.3%) |
| Dec 2020 | $117.77 M(+1.2%) | $117.77 M(-5.1%) |
| Sept 2020 | - | $124.05 M(+3.3%) |
| June 2020 | - | $120.13 M(-0.2%) |
| Mar 2020 | - | $120.32 M(+3.4%) |
| Dec 2019 | $116.37 M | $116.37 M(-0.9%) |
| Sept 2019 | - | $117.40 M(+1.1%) |
| June 2019 | - | $116.09 M(+70.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $68.30 M(+1.2%) |
| Dec 2018 | $67.48 M(-7.1%) | $67.48 M(+2.8%) |
| Sept 2018 | - | $65.62 M(-1.7%) |
| June 2018 | - | $66.78 M(-4.0%) |
| Mar 2018 | - | $69.57 M(-4.2%) |
| Dec 2017 | $72.64 M(+2.5%) | $72.64 M(-2.8%) |
| Sept 2017 | - | $74.77 M(+0.2%) |
| June 2017 | - | $74.59 M(+2.7%) |
| Mar 2017 | - | $72.62 M(+2.5%) |
| Dec 2016 | $70.86 M(+17.5%) | $70.86 M(-3.7%) |
| Sept 2016 | - | $73.60 M(+5.6%) |
| June 2016 | - | $69.71 M(+11.0%) |
| Mar 2016 | - | $62.81 M(+4.1%) |
| Dec 2015 | $60.32 M(-4.4%) | $60.32 M(+14.3%) |
| Sept 2015 | - | $52.79 M(-5.4%) |
| June 2015 | - | $55.80 M(-10.6%) |
| Mar 2015 | - | $62.45 M(-1.1%) |
| Dec 2014 | $63.11 M(-14.5%) | $63.11 M(-3.8%) |
| Sept 2014 | - | $65.63 M(-7.6%) |
| June 2014 | - | $71.01 M(-1.6%) |
| Mar 2014 | - | $72.19 M(-2.2%) |
| Dec 2013 | $73.81 M(+19.1%) | $73.81 M |
| Dec 2012 | $61.95 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual retained earnings year-on-year change?
- What is Amphastar Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly retained earnings year-on-year change?
What is Amphastar Pharmaceuticals annual retained earnings?
The current annual retained earnings of AMPH is $409.27 M
What is the all time high annual retained earnings for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual retained earnings is $409.27 M
What is Amphastar Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, AMPH annual retained earnings has changed by +$137.54 M (+50.62%)
What is Amphastar Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of AMPH is $530.82 M
What is the all time high quarterly retained earnings for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly retained earnings is $530.82 M
What is Amphastar Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, AMPH quarterly retained earnings has changed by +$157.72 M (+42.27%)